Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries
DiscussionThe PREVAC trial is evaluating —placebo-controlled—two promising Ebola candidate vaccines in advanced stages of development. The results will address unanswered questions related to short- and long-term safety and immunogenicity for three vaccine strategies in adults and children.Trial registrationClinicalTrials.govNCT02876328. Registered on 23 August 2016. (Source: Trials)
Source: Trials - January 23, 2021 Category: Research Source Type: clinical trials
Study of COVID-19 Outbreak in Hospital Departments of Bamako, Mali
Condition: Covid19 Interventions: Diagnostic Test: SARS-CoV-2 screening by molecular biology; Diagnostic Test: Serological screening Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 14, 2021 Category: Research Source Type: clinical trials
